Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study)

Blood Pressure

Volumn 18, Issue 4, 2009, Pages 180-186

  Gerdts, Eva ^a,b   Franklin, Stanley ^c   Rieck, Shild ^b   Papademetriou, Vasilios ^d   Wachtell, Kristian ^e   Nieminen, Markku ^f   Dahlf, Bjrn ^g   Devereux, Richard Blyton ^h  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Rigshospitalet   (Denmark)

^f UNIVERSITY OF HELSINKI   (Finland)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Ejection fraction; Hypertension; Left ventricular hypertrophy; Pulse pressure

Indexed keywords

ATENOLOL; LOSARTAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART STROKE VOLUME; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PULSE PRESSURE; TREATMENT RESPONSE;

AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 70849131685     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050903047202     Document Type: Article

References (33)

1. Nichols WW, O'Rourke MF. Properties of the arterial wall. In: McDonald's blood flow in arteries: Theoretical, experimental and clinical principles. 4th edn. London: Edward Arnold; 1998.
2. Devereux RB, Casale PN, Hammond IW, Savage DD, Alderman MH, Campo E, et al. Echocardiographic detection of pressure-overload left ventricular hypertrophy: effect of criteria and patient population. JClin Hypertens. 1987;3:66-78.
3. Pannier B, Brunel P, El Aroussy W, Lacolley P, Safar ME. Pulse pressure and echocardiographic findings in essential hypertension. JHypertens. 1989;7:127-132. (Pubitemid 19073988)
4. James MA, Watt PAC, Potter JF, Thurston H, Swales JD. Pulse pressure and resistance artery structure in the elderly. Hypertension. 1995;26:301-306.
5. Cirillo M, Stellato D, Laurenzi M, Panarelli W, Zanchetti A, De Santo NG, for the Gubbio Study Collaborative Research Group. Pulse pressure and isolated systolic hypertension: Association with microalbuminuria. Kidney Int. 2000;58:1211-1218.
6. Millar JA, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRCMild Hypertension Trial. JHypertens. 1999;8:1065-1072.
7. Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L, et al. Pulse pressure, not mean pressure, determines cardiovascular risk in older hypertensive patients. Arch Intern Med. 2000;160:1085-1089.
8. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23:395-401. (Pubitemid 24076725)
9. Vaccarino V, Berger AK, Abramson J, Black HR, Setaro JF, Davey JA, Krumholz HM. Pulse pressure and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program. Am JCardiol. 2001;88:980-986.
10. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, Stough WG, et al., for the OPTIMIZE-HFinvestigators and coordinators. Systolic blood pressure at admission, clinical characteristics and outcomes in patients with acute heart failure. JAMA. 2006;296:2217-2226.
11. Rönnback M, Isomaa B, Fagerudd J, Forsblom C, Groop PH, Tuomi T, et al., for the Botnia Study Group. Complex relationship between blood pressure and mortality in type-2 diabetic patients: Afollow-up of the Botnia study. Hypertension. 2006;47:168-173.
12. Schillaci G, Di Luzio SD, Coluccini M, Gonzini L, Porcu M, Pozzar F, et al., on behalf of the Italian Network on Congestive Heart Failure Registry. Alow pulse pressure is an independent predictor of mortality in heart failure: data from a large nationwide cardiology database (IN-CHFRegistry). Ital Heart J. 2004;5:892-898.
13. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA. 2002;287:1548-1555.
14. Dahlöf B, Devereux RB, kjeldsen SE, Julius S, Beevers G, de Faire U, et al., LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE ): a randomized trial against atenolol. Lancet. 2002;359:995-1003. (Pubitemid 34286536)
15. Devereux RB, Dahlöf B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: The LIFE trial. Circulation. 2004;110:1456-1462.
16. Jensen JS, Clausen P, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Detecting microalbuminuria by urinary albumin/ creatinine concentration ratio. Nephrol Dial Transplant. 1997;12(Suppl. 2): 6-9.
17. WHOStudy Group. Diabetes mellitus (technical report series 727). Geneva: WHO; 1985.
18. Devereux RB, Bella J, Boman K, Gerdts E, Nieminen M, Rokkedal J, et al. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. Blood Press. 2001;10:74-82. (Pubitemid 32640567)
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al.; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: Areport from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. JAm Soc Echocardiogr. 2005;18:1440-1463.
20. Teichholz LE, kreulen T, Herman, Gorlin R. Problems in echocardiographic volume determinations: Echocardiographic/ angiographic correlations in the presence of asynergy. Am JCardiol. 1976;37:7-11.
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am JCardiol. 1986;57:450-458.
22. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects. Hypertension Genetic Epidemiology Network (HyperGEN). Circulation. 2001;103:102-107. (Pubitemid 32050443)
23. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Relation of arterial structure and function to left ventriculargeometric patterns in hypertensive adults. JAm Coll Cardiol. 1996;28:751-756.
24. Devereux RB, Dahlöf B, Levy D, Pfeffer MA. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVEtrial). Am JCardiol. 1996;78:61-65.
25. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, et al. Assessment of left ventricular function by midwall fractional shortening/end-systolic stress relation in human hypertension. JAm Coll Cardiol. 1994;23:1444-1451. Erratum. JAm Coll Cardiol 1994;24:844 .
26. Gaasch WS, Zile MR, Hosino PK, Apstein CS, Blaustein AS. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation. 1989;79:872-883.
27. Dubin J, Wallerson DC, Cody RJ, Devereux RB. Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determinations. Am Heart J. 1990;120:116-123.
28. Lebowitz NE, Bella JN, Roman MJ, Liu JE, Fishman DP, Paranicas M, et al. Prevalence and correlates of aortic regurgitation in American Indians: The Strong Heart Study. JAm Coll Cardiol. 2000;36:461-467.
29. Jones EC, Devereux RB, Roman MJ, Liu JE, Fishman DP, Lee ET, et al. Prevalence and correlates of mitral regurgitation in a population-based sample (The Strong Heart Study). Am JCardiol. 2001;87:298-304.
30. Fyhrquist F, Dahlöf B, Devereux RB, kjeldsen SE, Julius S, Beevers G, et al., LIFE study group. Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy. Hypertension. 2005;45:580-585.
31. Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension. 2005;45:907-913.
32. Mitchell GF, Moyé LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM, et al. for the SAVEinvestigators. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. Circulation. 1997;96:4254-4260.
33. Safar ME. Pulse pressure in essential hypertension: Clinical and therapeutical implications. JHypertens. 1989;7:769-776